TRANSGENE
🏢 View company profile →4Patents
2Active
4Granted
35Portfolio score
Filing activity: Apr 1, 2003 → Mar 7, 2019
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7256036B2 | Modified adenoviral fiber and target adenoviruses | Chemistry; Metallurgy | 9 | Expired |
| US7332478B2 | Antitumoral composition based on immunogenic polypeptide with modified cell location | Chemistry; Metallurgy | 2 | Expired |
| US12377142B2 | Recombinant pseudocowpoxvirus | Chemistry; Metallurgy | 0 | Active |
| US11969462B2 | Personalized vaccine | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.